{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T11:47:20Z","timestamp":1749124040491},"reference-count":49,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[1990,7,1]],"date-time":"1990-07-01T00:00:00Z","timestamp":646790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology: Molecular Pharmacology"],"published-print":{"date-parts":[[1990,7]]},"DOI":"10.1016\/0922-4106(90)90230-u","type":"journal-article","created":{"date-parts":[[2003,3,4]],"date-time":"2003-03-04T15:38:35Z","timestamp":1046792315000},"page":"59-70","source":"Crossref","is-referenced-by-count":20,"title":["Optically active benzamides as predictive tools for mapping the dopamine D2 receptor"],"prefix":"10.1016","volume":"189","author":[{"given":"Didier","family":"Rognan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Sokoloff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Pascale","family":"Martres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Charles","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean","family":"Costentin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille-Georges","family":"Wermuth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/0922-4106(90)90230-U_BIB1","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF00427315","article-title":"Effects of sulpiride and chlorpromazine on autistic and positive psychotic symptoms in schizophrenic patients. Relationship to drug concentrations","volume":"85","author":"Alfredsson","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/0922-4106(90)90230-U_BIB2","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1139\/v76-385","article-title":"Crystallographic studies on neuroleptics of the benzocycloheptapyridoisoquinolin series. The crystal structure of butaclamol hydrobromide and the absolute configuration and crystal structure of dexclamol hydrobromide","volume":"54","author":"Bird","year":"1976","journal-title":"Can. J. Chem."},{"key":"10.1016\/0922-4106(90)90230-U_BIB3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/syn.890010408","article-title":"Review: D-1 dopamine receptor. The search of a function: a critical evaluation of the D-1\/D-2 dopamine receptor classification and its functional","volume":"1","author":"Clark","year":"1987","journal-title":"Synapse"},{"key":"10.1016\/0922-4106(90)90230-U_BIB4","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1002\/jps.2600731125","article-title":"Synthesis and dopaminergic activity of 3-(3,4-dihydroxyphenyl)-1-n-propylpyrrolidine hydrobromide","volume":"73","author":"Crider","year":"1984","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/0922-4106(90)90230-U_BIB5","series-title":"Proc. 8th Int. Symp. Med. Chem.","first-page":"2","article-title":"Substituted benzamides. The development of selective dopamine antagonists","author":"De Paulis","year":"1984"},{"key":"10.1016\/0922-4106(90)90230-U_BIB6","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0028-3908(77)90070-3","article-title":"Substituted benzamides as cerebral dopamine antagonists in rodents","volume":"16","author":"Elliot","year":"1977","journal-title":"Neuropharmacology"},{"key":"10.1016\/0922-4106(90)90230-U_BIB7","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1246\/bcsj.55.2321","article-title":"New potent neuroleptic drug of benzamide derivatives. I. Crystal and molecular structure of N-[(RSBRS)-1-benayl-2-methyl-3-pyrrolidinyl]-5chloro-2-methoxy-4-methyl amino benzamide","volume":"55","author":"Furuya","year":"1982","journal-title":"Bull. Soc. Chem. Jpn."},{"key":"10.1016\/0922-4106(90)90230-U_BIB8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0223-5234(87)90172-3","article-title":"(T\u00e9trahydro-1,2,3,6 pyridinyl-4)-3-1H-indoles: synth\u00e8se, propri\u00e9t\u00e9s s\u00e9rotoninergiques et anti-dopaminergiques","volume":"22","author":"Guillaume","year":"1987","journal-title":"European J. Med. Chem."},{"key":"10.1016\/0922-4106(90)90230-U_BIB9","first-page":"38","article-title":"Neuroleptic activity of the 5-aryltetrahydro-\u03b3-carboline series. Conformational requirements for the interaction with central dopamine receptors","volume":"17","author":"Harbert","year":"1980","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/0922-4106(90)90230-U_BIB10","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1021\/jm00392a019","article-title":"Charged analogs of chlorpromazine as dopamine antagonists","volume":"30","author":"Harrold","year":"1987","journal-title":"J. Med. Chem."},{"key":"10.1016\/0922-4106(90)90230-U_BIB11","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.2042-7158.1975.tb09506.x","article-title":"Dopamine receptor blockade and the neuroleptics, a crystallographic study","volume":"27","author":"Horn","year":"1970","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/0922-4106(90)90230-U_BIB12","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1107\/S0567740881004858","article-title":"N-[(Ethyl-1-pyrrolidinyl)-2 methyl] methoxy-2 sulfamoyl-5benzamide (sulpiride)","volume":"B37","author":"Houttemane","year":"1981","journal-title":"Acta Crystallogr."},{"key":"10.1016\/0922-4106(90)90230-U_BIB13","first-page":"833","article-title":"Neuroleptic agents of the benzo-cyclohepta-pyridoisoquinoline series: a hypothesis on their mode of interaction with the central dopamine receptor","volume":"11","author":"Humber","year":"1975","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/0922-4106(90)90230-U_BIB14","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1021\/jm00368a011","article-title":"Design, synthesis, and X-ray data of novel potential antipsychotic agents. Substituted 7-phenyl quinolizidines: stereospecific, neuroleptic, and antinociceptive properties","volume":"27","author":"Imhof","year":"1984","journal-title":"J. Med. Chem."},{"key":"10.1016\/0922-4106(90)90230-U_BIB15","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.2042-7158.1980.tb12842.x","article-title":"Stereoselective actions of substituted benzamine drugs on cerebral dopamine mechanisms","volume":"32","author":"Jenner","year":"1982","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/0922-4106(90)90230-U_BIB16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.2042-7158.1978.tb13151.x","article-title":"A comparison of in vitro and in vivo dopamine receptor antagonism produced by substituted benzamide drugs","volume":"30","author":"Jenner","year":"1978","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/0922-4106(90)90230-U_BIB17","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/0024-3205(79)90559-9","article-title":"The substituted benzamides. A novel class of dopamine antagonists","volume":"25","author":"Jenner","year":"1979","journal-title":"Life Sci."},{"key":"10.1016\/0922-4106(90)90230-U_BIB18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/277093a0","article-title":"Multiple receptors for dopamine","volume":"277","author":"Kebabian","year":"1979","journal-title":"Nature"},{"key":"10.1016\/0922-4106(90)90230-U_BIB19","first-page":"226","article-title":"The thermodynamics of agonist and antagonist binding to dopamine D-2 receptors","volume":"30","author":"Kilpatrick","year":"1986","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/0922-4106(90)90230-U_BIB20","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1107\/S0567740873002621","article-title":"The crystal and molecular structure of 8-[3-(p-fluorobenzoyl)propyl]-1-phenyl-1,3,8-triazaspiro [4,5]decan-4-one, C23H26N3O2F","volume":"B29","author":"Koch","year":"1973","journal-title":"Acta Crystallogr."},{"key":"10.1016\/0922-4106(90)90230-U_BIB21","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/0028-3908(84)90034-0","article-title":"Sulpiride isomers exhibit reversed stereospecificity for D-1 and D-2 dopamine receptors in the CNS","volume":"23","author":"Leff","year":"1984","journal-title":"Neuropharmacology"},{"key":"10.1016\/0922-4106(90)90230-U_BIB22","first-page":"99","article-title":"A simplified method for evaluating dose-effect experiments","volume":"96","author":"Litchfield","year":"1949","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/0922-4106(90)90230-U_BIB23","first-page":"2861","article-title":"The antischizophrenic agent sulpiride: structures of the S (-)-enantiomer and the racemate","volume":"B38","author":"Ma.L.Y.Y.","year":"1982","journal-title":"Acta Crystallogr."},{"key":"10.1016\/0922-4106(90)90230-U_BIB24","series-title":"Computer-Assisted Drug Design","first-page":"205","article-title":"The conformational parameters in drug design: the active analog approach","volume":"Vol. 112","author":"Marshall","year":"1979"},{"key":"10.1016\/0922-4106(90)90230-U_BIB25","series-title":"Proc. 2nd SCI-RSC Med. Chem. Symp. Chem. Soc.","first-page":"96","article-title":"Systematic conformational search: use and visualization","author":"Marshall","year":"1984"},{"key":"10.1016\/0922-4106(90)90230-U_BIB26","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1126\/science.3838821","article-title":"widespread distribution of brain dopamine receptors evidenced with [125I]iodosulpride, a highly selective ligand","volume":"228","author":"Martres","year":"1985","journal-title":"Science"},{"key":"10.1016\/0922-4106(90)90230-U_BIB27","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/BF00506189","article-title":"Selection of dopamine antagonists discriminating various behavioural responses and radioligand binding sites","volume":"325","author":"Martres","year":"1984","journal-title":"Naunyn-Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/0922-4106(90)90230-U_BIB28","series-title":"Crystal Structure of Zetidoline. M\u00e9moire Licence Sciences Chimiques","author":"Moureau","year":"1987"},{"key":"10.1016\/0922-4106(90)90230-U_BIB29","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1600-0447.1984.tb06857.x","article-title":"Sulpiride versus haloperiodol, a clinical trial in schizophrenia","volume":"69","author":"Munk-Andersen","year":"1984","journal-title":"Acta Psychiatr. Scand. Swed."},{"key":"10.1016\/0922-4106(90)90230-U_BIB30","first-page":"430","article-title":"[3H]RO22-1319 (piquindone) binds to the D2 dopaminergic receptor subtype in a sodium-dependent manner","volume":"26","author":"Nakajima","year":"1984","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/0922-4106(90)90230-U_BIB31","doi-asserted-by":"crossref","first-page":"10909","DOI":"10.1016\/S0021-9258(19)70393-7","article-title":"Characterization, solubilization and separation of two distinct dopamine receptors in canine caudate nucleus","volume":"255","author":"Nishikori","year":"1980","journal-title":"J. Biol. Chem."},{"key":"10.1016\/0922-4106(90)90230-U_BIB32","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1021\/jm00141a002","article-title":"A dopamine receptor model and its application in the design of a new class of rigid pyrrolo [2,3-g] isoquinoline antipsychotics","volume":"24","author":"Olson","year":"1981","journal-title":"J. Med. Chem."},{"key":"10.1016\/0922-4106(90)90230-U_BIB33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.2042-7158.1981.tb13737.x","article-title":"A theoritical conformational study of substituted O-anisamides as models of a class of dopamine antagonists","volume":"33","author":"Pannatier","year":"1981","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/0922-4106(90)90230-U_BIB34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0028-3908(77)90023-5","article-title":"Neuroleptic drug interactions with norepinephrine alpha receptor binding sites in rat brain","volume":"16","author":"Peroutka","year":"1977","journal-title":"Neuropharmacology"},{"key":"10.1016\/0922-4106(90)90230-U_BIB35","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1039\/p29760001415","article-title":"Conformations of some semi-rigid neuroleptic drugs. Part 1. Crystal structure of loxapine, clozapine and HUF-2046 monohydrate","volume":"11","author":"Petcher","year":"1976","journal-title":"J. Chem. Soc. Perkin Trans."},{"key":"10.1016\/0922-4106(90)90230-U_BIB36","doi-asserted-by":"crossref","first-page":"1886","DOI":"10.1107\/S0567740873005704","article-title":"The crystal and molecular structure of haloperidol, a potent psychotropic drug","volume":"B29","author":"Reed","year":"1973","journal-title":"Acta Crystallogr."},{"key":"10.1016\/0922-4106(90)90230-U_BIB37","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1002\/jlcr.2580241113","article-title":"Synthesis of S-3H-DO 710, a benzamide ligand of the D-2 dopamine receptor and of S-3H-azidosulpride, its photoactivable analog","volume":"24","author":"Rognan","year":"1987","journal-title":"J. Lab. Comp. Radiopharm."},{"key":"10.1016\/0922-4106(90)90230-U_BIB38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1021\/jm00151a002","article-title":"Neuroleptic activity of trans-Hexahydro-carbolines","volume":"29","author":"Sarges","year":"1986","journal-title":"J. Med. Chem."},{"key":"10.1016\/0922-4106(90)90230-U_BIB39","series-title":"Catecholamines: Neuropharmacology and Central Nervous System Theoretical Aspects","first-page":"59","article-title":"Biochemical and behavioural identification of discriminant benzamide derivatives: new tools to differentiate subclasses of dopamine receptors","author":"Schwartz","year":"1984"},{"key":"10.1016\/0922-4106(90)90230-U_BIB40","first-page":"760","article-title":"Dopamine D1 and D2 receptors are sensitive to the cationic form of apomorphine","volume":"32","author":"Seeman","year":"1987","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/0922-4106(90)90230-U_BIB41","first-page":"391","article-title":"Dopamine D2 receptor binding sites for agonists. A tetrahedral model","volume":"28","author":"Seeman","year":"1985","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/0922-4106(90)90230-U_BIB42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/BF00502453","article-title":"3H-domperidone binding sites differ in rat striatum and pituitary","volume":"327","author":"Sokoloff","year":"1984","journal-title":"Naunyn-Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/0922-4106(90)90230-U_BIB43","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/BF00501874","article-title":"3H-DO 710 discriminates between guanine nucleotide sensitive and insensitive dopamine binding sites","volume":"329","author":"Sokoloff","year":"1985","journal-title":"Naunyn-Schmiedeb. Arch. Pharmacol."},{"key":"10.1016\/0922-4106(90)90230-U_BIB44","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/0024-3205(75)90176-9","article-title":"Sulpride: a study of the effects on dopamine receptors in rat neostriatum and limbic forebrain","volume":"17","author":"Trabucchi","year":"1975","journal-title":"Life Sci."},{"key":"10.1016\/0922-4106(90)90230-U_BIB45","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1107\/S0567740877004221","article-title":"1-(1-[4,4-Bis(4-fluorophenyl)butyl]-4-piperidyl)-5-chloro-1,3-dihydro-2H-2Hbenzimidazol-2-one: clopimozide","volume":"B33","author":"Van Opdenbosh","year":"1977","journal-title":"Acta Crystallogr."},{"key":"10.1016\/0922-4106(90)90230-U_BIB46","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1021\/jm00394a028","article-title":"2-Phenylpyrroles as conformationally restricted benzamide analogues. New class of potential antipsychotics 1","volume":"30","author":"Van Vijngaarden","year":"1987","journal-title":"J. Med. Chem."},{"key":"10.1016\/0922-4106(90)90230-U_BIB47","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/0014-2999(87)90544-9","article-title":"Antagonism by neuroleptics of serotonin 5-HT1A and 5-HT2 receptors of normal brain in vitro","volume":"143","author":"Wander","year":"1987","journal-title":"European J. Pharmacol."},{"key":"10.1016\/0922-4106(90)90230-U_BIB48","first-page":"61","article-title":"Strategic approaches to drug design. I. An integrated software framework for molecular modelling","volume":"1","author":"Winter","year":"1987","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/0922-4106(90)90230-U_BIB49","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1021\/jm00153a010","article-title":"Synthesis and biological evaluation of 1-(1,2-benzisothiazol-3-yl) and (1,2-benzisoxazol-3-yl) piperazine derivatives as potential antipsychotic agents","volume":"29","author":"Yevich","year":"1986","journal-title":"J. Med. Chem."}],"container-title":["European Journal of Pharmacology: Molecular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:092241069090230U?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:092241069090230U?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,6,5]],"date-time":"2021-06-05T00:05:45Z","timestamp":1622851545000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/092241069090230U"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,7]]},"references-count":49,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,7]]}},"alternative-id":["092241069090230U"],"URL":"https:\/\/doi.org\/10.1016\/0922-4106(90)90230-u","relation":{},"ISSN":["0922-4106"],"issn-type":[{"value":"0922-4106","type":"print"}],"subject":[],"published":{"date-parts":[[1990,7]]}}}